Abstract:Background: Hyperphenylalaninemia (HPA) is defined as blood phenylalanine (Phe) levels exceeding the normal values (>120 μmol/L or >2 mg/dL) and is caused by a deficiency in the enzyme phenylalanine hydroxylase (PAH). The widespread screening of Phe levels in newborn screening programs has led to a very high number of patients with HPA. Methods: The samples were collected at various ages, not at the point of diagnosis. Nine pterin derivatives, including isoxanthopterin, sepiapterin, xanthopterin, primapterin, biopterin, neopterin, 7,8-dihydrobiopterin, 7,8-dihydroneopterin, and tetrahydrobiopterin (BH4), were analyzed in different HPA classes in serum, dried blood spots (DBS), and urine samples. A total of 18 patients, including six classical phenylketonuria (PKU), eight BH4-responsive PKU, and four mild HPA patients, were included in the study. Results: Among the nine pterin derivatives measured, a significant increase was observed in the levels of isoxanthopterin, biopterin, and 7,8-dihydrobiopterin in serum, dried blood spots (DBS), and urine samples of patients with HPA compared to the control group. However, elevations in isoxanthopterin, biopterin, and 7,8-dihydrobiopterin were observed in all HPA groups, although the extent of elevation varied among the different disease groups. There were also significant differences between HPA subgroups among these high values. Conclusion: In this study, it might be suggested that pterin profiling shows promising potential for its effective utilization in the differential diagnosis of HPA. Pterin profiling demonstrated its efficacy in accurately categorizing patients into distinct subtypes. This approach offers several notable advantages, including the ability to simultaneously screen multiple HPA subtypes through a single test, establish disease decision limits for pterins, shorten the time required for HPA differential diagnosis, reduce the risk of misdiagnosis, and increase overall diagnostic accuracy. This study is the most comprehensive study examining the association between HPA pterin in the literature. In our study, samples obtained from BH4-responsive PKU patients were on treatment. This may have affected the results. Preliminary findings on pterin profiles may need to be replicated in a prospective cohort of samples collected at the time of diagnosis to confirm the results.

Clinical and genetic analysis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

Clinical Phenotype of Different Hyperphenylalaninemia Patients

Mutations in Patients with Hyperphenylalaninemia in Zhejiang, China

Clinic studies on the different type of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency

[Clinical Study of Tetrahydrobiopterin Responsive Phenylalanine Hydroxylase Deficiency in Southern and Northern Chinese Patients].

Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies

Mutational and Phenotypic Spectrum of Phenylalanine Hydroxylase Deficiency in Zhejiang Province, China

Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population

Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study

Functional Characterization of Novel Phenylalanine Hydroxylase p.Gln226Lys Mutation Revealed Its Non-responsiveness to Tetrahydrobiopterin Treatment in Hepatoma Cellular Model

[Pseudohypoparathyroidism and GNAS Gene Defects: Clinical Evaluation and Molecular Analysis in 20 Children].

Disorders of Bh4 Metabolism and the Treatment of Patients with 6-Pyruvoyl-tetrahydropterin Synthase Deficiency in Taiwan

[Research Progress on Phenotype and Genotype of Hyperphenylalaninemia].

Clinical, genetic, and experimental research of hyperphenylalaninemia

Clinical and biochemical study for the diagnosis, treatment and prenatal diagnosis of tetrahydrobiopterin deficiency due to 6-pyruvoyl tetrahydropterin synthase deficiency

Rare hypertension as a result of 17alpha-hydroxylase deficiency.

[In Vitro Expression and Structural Analysis of Four Missense Mutations (G247S, E280G, P362T, A434D) of Phenylalanine Hydroxylase Gene].

Long-term follow-up of Chinese patients who received delayed treatment for 6-pyruvoyl-tetrahydropterin synthase deficiency.

Pterin Profiling in Serum, Dried Blood Spot, and Urine Samples Using LC-MS/MS in Patients with Inherited Hyperphenylalaninemia

[Genetic analysis of eighteen patients from Gansu Province with Tetrahydrobiopterin deficiency]

MR Study of the Brain in Patients with Tetrahydrobiopterin Deficiency